Ondo’s New Healthcare Revolution: From Medicine Security to Better Diagnosis, Aiyedatiwa Sets Fresh Agenda

As state approves Pharmaceutical and Life Sciences Hub, moves to strengthen drug distribution, diagnostics and private-sector investment

By The Pivot Online News Desk

AKURE — The Ondo State Government has unveiled a fresh healthcare reform agenda that could significantly reshape the state’s health sector, with a major focus on medicines security, local pharmaceutical production, improved diagnostic services and increased private-sector participation.

Governor Lucky Orimisan Aiyedatiwa has also approved the procurement of critical diagnostic equipment for healthcare facilities, a move the government says will strengthen early disease detection, clinical decision-making and patient outcomes.

But perhaps the most consequential part of the reform is the planned repositioning of the Ondo State Drugs and Health Commodities Management Agency (OSDHCMA) into a State Drugs and Health Commodities Distribution Centre capable of supplying both public and private healthcare institutions.

The objective is clear: build a more reliable medicines supply chain and reduce the vulnerabilities associated with dependence on external sources.

The question now is whether the ambitious plans can be translated into a sustainable system that patients across Ondo State can actually feel.

A NEW APPROACH TO MEDICINE SECURITY

For years, access to medicines has remained one of the central issues confronting healthcare delivery in Nigeria.

Ondo’s latest strategy attempts to address the problem at its source rather than treating medicine availability simply as a procurement issue.

The Senior Consultant on Pharmaceutical and Medical Investments to the state government, Dr Samuel Adekola, said the proposed Pharmaceutical and Life Sciences Hub would strengthen the state’s health and economic security by supporting local manufacturing and biotechnology research.

The initiative is also expected to attract investors and create a pharmaceutical manufacturing ecosystem within the state.

This represents a shift from simply purchasing medicines to building capacity to produce, manage and distribute them.

The idea had already received attention in July, when the state announced that the pharmaceutical and life sciences hubs had been approved under a public-private partnership arrangement, with the stated objective of attracting investment and promoting pharmaceutical manufacturing.

If successfully implemented, the initiative could give Ondo a stronger position in the regional healthcare economy.

But manufacturing is only one part of medicine security.

The medicines must still be properly procured, stored, distributed and delivered to the health facilities where patients need them.

That is where the proposed restructuring of OSDHCMA becomes important.

FROM WAREHOUSE TO DISTRIBUTION CENTRE

The government plans to reposition OSDHCMA as a State Drugs and Health Commodities Distribution Centre serving healthcare institutions within and outside Ondo State.

Adekola said the agency would be central to efforts to eliminate stock-outs, prevent the circulation of substandard medicines and improve transparency in procurement and distribution.

The plan is significant because a strong pharmaceutical manufacturing initiative cannot achieve its full purpose without an efficient distribution system.

Government says comprehensive operational guidelines are being developed, with stakeholders including the University of Medical Sciences Teaching Hospital, Ondo, expected to contribute to the framework.

The success of the new system will therefore depend not only on the creation of another institutional structure but on how efficiently the entire supply chain operates.

That means procurement, storage, inventory management, transportation, monitoring and accountability must work together.

DIAGNOSIS BEFORE TREATMENT

The reforms also place considerable emphasis on diagnosis.

The state has approved the procurement of critical diagnostic equipment for healthcare facilities, recognising that effective treatment depends heavily on the ability of medical professionals to correctly identify diseases and conditions.

Without reliable diagnostic capacity, doctors may have limited information with which to make clinical decisions.

The proposed investment therefore has the potential to improve not only diagnosis but also the speed and accuracy of treatment.

For patients, the practical test will be whether the new equipment becomes available where it is needed, remains functional and is supported by qualified personnel capable of operating and maintaining it.

That will be particularly important beyond the state’s major urban centres.

UNIMEDTH AT THE CENTRE

The University of Medical Sciences Teaching Hospital has been identified as a critical institution in the implementation of the new reforms.

Adekola called for stronger collaboration between the teaching hospital and OSDHCMA, particularly in medicines management and supply-chain systems.

The Chief Medical Director of UNIMEDTH, Prof. Michael Gbala, welcomed the reforms and called for sustained improvement in the supply and management of medicines.

He specifically stressed the importance of ensuring that patients have access to essential and lifesaving medicines when required.

The comments are significant because they point to an important reality: infrastructure and policy reforms must ultimately support the clinical environment.

A new warehouse, pharmaceutical hub or diagnostic machine has limited value if the wider system cannot consistently deliver medicines, personnel and services to patients.

HEALTHCARE AND NUTRITION

Another component of the reform agenda is an evidence-based clinical nutrition model for in-patient care.

Under the proposed approach, nutrition would be treated as part of medical intervention rather than merely as a routine hospital service.

The government says patient meals would be tailored to medical conditions and recovery needs, with the aim of improving treatment outcomes, reducing complications and shortening hospital stays.

UNIMEDTH is expected to play a leading role in implementing and refining the model, while the state plans to partner with the West Africa Society of Parenteral and Enteral Nutrition.

It is an area that could give the reforms a broader dimension, moving healthcare beyond medicines and equipment to include the nutritional needs of patients during treatment.

PRIVATE CAPITAL ENTERS THE EQUATION

The government is also looking towards the private sector to expand healthcare capacity.

Areas identified for potential public-private partnerships include diagnostic services, medical imaging, specialised clinics, digital health infrastructure and biomedical engineering.

This is consistent with the state’s broader PPP framework, which provides for measurable outcomes, defined responsibilities and performance indicators in projects involving private-sector participation.

For healthcare, however, the challenge will be ensuring that private investment improves quality and access without making essential services unaffordable for ordinary residents.

That balance will be crucial.

THE BIG TEST: IMPLEMENTATION

Ondo State has announced ambitious reforms before, and the present initiative should therefore be judged not simply by the number of policies announced but by measurable outcomes.

The real test will be whether patients experience:

More reliable access to essential medicines.

Faster and more accurate diagnosis.

Better-equipped healthcare facilities.

Stronger pharmaceutical supply chains.

Improved clinical services.

Greater access to specialised healthcare.

And ultimately, better health outcomes.

The state has already demonstrated an interest in strengthening its medicines infrastructure. In June 2025, Governor Aiyedatiwa inaugurated an upgraded Central Medical Stores facility in Akure and said the state was taking steps to eliminate counterfeit medicines from its supply chain.

The new reforms therefore represent a continuation—and potentially an expansion—of that direction.

FROM ANNOUNCEMENT TO IMPACT

The ambition is considerable.

Ondo wants to strengthen its medicine supply chain, encourage pharmaceutical manufacturing, improve diagnostics, introduce more evidence-based clinical nutrition, attract private capital and position its health institutions for greater efficiency.

But ultimately, healthcare reform is not measured by the number of policies announced.

It is measured at the point where a patient meets the health system.

The success of the new agenda will therefore depend on implementation, funding, transparency, professional capacity, maintenance of equipment and the ability to ensure that improvements reach communities beyond the major centres.

For Governor Aiyedatiwa’s administration, the challenge now is to move the reforms from policy documents to measurable results.

And for the people of Ondo State, the question is simple:

When will the new healthcare revolution be felt in the lives of ordinary patients?

That is where the real story begins.